With IPF, once damage occurs, it cannot be undone. That is why it is important to slow your IPF from progressing. The goal of treatment is to help slow progression of the disease.
Many people only learn that they have IPF
after experiencing symptoms for quite some
time, or even after the disease has
already progressed. That’s because early
symptoms of IPF often resemble those of
other conditions. Some of the early signs
will be noticeable to you, while others
may only be detected during an examination
by your doctor.
Understanding the common signs and symptoms of IPF and discussing them with your doctor can often help to detect IPF early and give you more time to work with your doctor on a treatment plan. Esbriet® (pirfenidone) does not treat the symptoms of IPF and does not reverse the scarring in your lungs.
Early symptoms of IPF
Additional symptoms may appear as IPF progresses
Keep in mind that each person responds to IPF differently and may experience some or all of these signs and symptoms.
There are tests that measure lung function. Your doctor can give you more information. One test your doctor may do is a forced vital capacity (FVC) test:
Your doctor may have you do physical activities. For example, one type of test looks at how far you can walk in a set amount of time. Another test checks your oxygen saturation while you walk. A third one measures how quickly you recover after walking.
There are scans your doctor can do to see what is happening inside your lungs. One type of scan is called an HRCT scan.
Since everyone is different, your doctor will decide which tests are best for measuring how your IPF is progressing. Ask your doctor about which tests may be right for you.
Take action now and talk to your doctor.
Take an active role in managing your condition.
The link you have selected will take you away from this site to one that is not owned or controlled by Legacy Pharma Inc. SEZC. Legacy Pharma Inc. SEZC makes no representation as to the accuracy of the information contained on sites we do not own or control. Legacy Pharma Inc. SEZC does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.